PSATluca is a lovely nomogram module, which integrated CYPRF21-1 level, age at diagnosis, gender, histology type, treatment history, metastasis status, and could predict the lung cancer patient survival probability and guide following clinical therapeutic treatment selection.

To use PSATluca, you need to select six clinical characteristics of LUCA patients, including age at diagnosis, gender, histology type, treatment, metastasis and CYFRA21-1 concentration. Once these values have been selected, click on the "Calculate" button, after then, corresponding 12-month, 36-month and 60-month survival probabilities for typed patient will be presented, relative treatment suggestion will be given.